|
Association of GRS with T2D prevalence at enrollment |
Study |
OR (95% CI, tertile 3 vs. tertile 1; P-value) |
P for trend |
ARIC |
1.78 (1.45-2.19; P<0.0001) |
<0.0001 |
FOS |
-- |
-- |
MESA |
2.63 (1.97-3.51; P<0.0001) |
<0.0001 |
Pooled |
2.15 (1.47-3.14; P<0.0001) |
1.5×10-10 |
Association of GRS with T2D prevalence at the end of follow-up |
Study |
OR (95% CI, tertile 3 vs. tertile 1; P-value) |
P for trend |
ARIC |
1.64 (1.39-1.92; P<0.0001) |
<0.0001 |
FOS |
2.65 (1.78-3.96; P<0.0001) |
<0.0001 |
MESA |
2.18 (1.71-2.78; P<0.0001) |
<0.0001 |
Pooled |
2.08 (1.59-2.74; P<0.0001) |
4.9×10-12 |
Association of GRS with incident T2D |
Study |
HR (95% CI, tertile 3 vs. tertile 1; P-value) |
P for trend |
ARIC |
1.31 (1.08-1.57; P=0.0008) |
0.0008 |
FOS |
2.64 (1.84-3.79; P<0.0001) |
<0.0001 |
MESA |
1.32 (0.95-1.83; P=0.10) |
0.26 |
Pooled |
1.62 (1.08-2.44; P=0.02) |
1.5×10-14 |
*All ORs and P-values adjusted for age, sex, race, current smoking, BMI, HDL, LDL and SBP |